Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 6/2011

01-11-2011 | Clinical Investigation

Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost

Authors: Makoto Aihara, Shiroaki Shirato, Rei Sakata

Published in: Japanese Journal of Ophthalmology | Issue 6/2011

Login to get access

Abstract

Purpose

To investigate the incidence of deepening of the upper eyelid sulcus (DUES) after use of bimatoprost in Japanese glaucoma patients.

Methods

Twenty-five open-angle glaucoma Japanese patients treated with latanoprost in both eyes for 6 months or longer and needing further intraocular pressure (IOP) reduction were enrolled prospectively. Latanoprost was switched to bimatoprost, and the patients were observed at 1, 3, and 6 months. The patients were queried for the presence of DUES at every visit. Sex, refraction, and IOP were evaluated as related factors. The photographs of the eyes and forehead taken at each of the four visits were randomly displayed and judged for the presence of DUES with unanimous confirmation by three examiners.

Results

One month after the switch to bimatoprost, 44% (11/25) of the patients had DUES, including three with unilateral DUES. At 3 and 6 months, 60% (15/25) of the patients had DUES. The incidence was significantly higher in older patients and nonmyopic eyes (P < 0.01), but not related to sex or IOP reduction. Finally, 53.3% (8/15) of the patients objectively judged to have DUES noticed the presence of DUES by themselves. Only one patient dropped out of the study because of DUES (after 3 months).

Conclusion

DUES is an often-observed side effect of bimatoprost topical treatment in Japanese glaucoma patients.
Literature
1.
2.
go back to reference Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008;24:302–7.PubMedCrossRef Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008;24:302–7.PubMedCrossRef
3.
go back to reference Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy: an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29:357–9.PubMedCrossRef Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy: an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29:357–9.PubMedCrossRef
4.
go back to reference Peplinski LS, Albiani Smith K. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci. 2004;81:574–7.PubMedCrossRef Peplinski LS, Albiani Smith K. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci. 2004;81:574–7.PubMedCrossRef
5.
go back to reference Tappeiner C, Perren B, Iliev ME, Frueh BE, Goldblum D. Orbital fat atrophy in glaucoma patients treated with topical bimatoprost: can bimatoprost cause enophthalmos? Klin Monbl Augenheilkd. 2008;225:443–5.PubMedCrossRef Tappeiner C, Perren B, Iliev ME, Frueh BE, Goldblum D. Orbital fat atrophy in glaucoma patients treated with topical bimatoprost: can bimatoprost cause enophthalmos? Klin Monbl Augenheilkd. 2008;225:443–5.PubMedCrossRef
6.
go back to reference Yam JC, Yuen NS, Chan CW. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J Ocul Pharmacol Ther. 2009;25:471–2.PubMedCrossRef Yam JC, Yuen NS, Chan CW. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J Ocul Pharmacol Ther. 2009;25:471–2.PubMedCrossRef
7.
go back to reference Yang HK, Park KH, Kim TW, Kim DM. Deepening of eyelid superior sulcus during topical travoprost treatment. Jpn J Ophthalmol. 2009;53:176–9.PubMedCrossRef Yang HK, Park KH, Kim TW, Kim DM. Deepening of eyelid superior sulcus during topical travoprost treatment. Jpn J Ophthalmol. 2009;53:176–9.PubMedCrossRef
8.
go back to reference Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol. 2002;47(Suppl 1):S162–75.PubMedCrossRef Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol. 2002;47(Suppl 1):S162–75.PubMedCrossRef
9.
go back to reference Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, et al. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br J Pharmacol. 2008;154:1079–93.PubMedCrossRef Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, et al. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br J Pharmacol. 2008;154:1079–93.PubMedCrossRef
10.
go back to reference Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation. 1996;60:203–10.PubMedCrossRef Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation. 1996;60:203–10.PubMedCrossRef
11.
go back to reference Liu L, Clipstone NA. Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium–calcineurin-dependent signaling pathway. J Cell Biochem. 2007;100:161–73.PubMedCrossRef Liu L, Clipstone NA. Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium–calcineurin-dependent signaling pathway. J Cell Biochem. 2007;100:161–73.PubMedCrossRef
12.
go back to reference Serrero G, Lepak NM. Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997;233:200–2.PubMedCrossRef Serrero G, Lepak NM. Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997;233:200–2.PubMedCrossRef
Metadata
Title
Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost
Authors
Makoto Aihara
Shiroaki Shirato
Rei Sakata
Publication date
01-11-2011
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 6/2011
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-011-0075-6

Other articles of this Issue 6/2011

Japanese Journal of Ophthalmology 6/2011 Go to the issue